CRANAD-28

• UNSPSC Description:

  CRANAD-28 is a robust fluorescent compound for visualization of amyloid beta plaques[1].

• Target Antigen:

  Fluorescent Dye

• Type:

  Dye Reagents

• Related Pathways:

  Others

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/cranad-28.html

• Purity:

  98.03

• Solubility:

  DMSO : 5 mg/mL (ultrasonic;warming;heat to 60°C)

• Smiles:

  CC(N(C1=CC=CC=C1)N=C2)=C2/C=C/C([CH-]C(/C=C/C(C=NN3C4=CC=CC=C4)=C3C)=[O]5)=[O][B+3]5([F-])[F-]

• Molecular Weight:

  484.30

• References & Citations:

  [1]Kathleen Ran, et al. CRANAD-28: A Robust Fluorescent Compound for Visualization of Amyloid Beta Plaques. Molecules. 2020 Feb 16;25(4):863.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Clinical Information:

  No Development Reported

• CAS Number:

  1623747-97-6